HONG KONG, March 15 /PRNewswire-Asia/ -- Golden Meditech Holdings Limited ("Golden Meditech" or "the Group"; Stock Code: 801), China's leading integrated healthcare device and service enterprise, is pleased to announce today that the Group's shareholders (the "Shareholders") have approved at an Extraordinary General Meeting (the "EGM") held today, a special resolution as proposed by the board of directors ("the Board") to change the Group's name into "Golden Meditech Holdings Limited."
The Group's diversified business portfolio currently includes the core and wholly-owned operation of Beijing Jingjing Medical Equipment Co., Ltd., renowned as China's first and largest manufacturer of autologous blood recovery device, and a hospital management arm that is the first foreign-owned entity in China to offer nationwide hospital management and consultancy services. In addition, the Group also has a majority stake in China Cord Blood Corporation ( CO), the first and largest cord blood bank operator in China, and FunTalk China Holdings Limited (NDAQ: FTLK), a thriving fast-moving consumer electronics goods retailer in China.
Commenting on the significance of name change, Mr. KAM Yuen, Chairman and CEO of the Group, said, "While we already enjoy dominant positions in all of the different business market segments which we operate, our expertise and in- depth knowledge in China market has rendered us in an excellent position to capture the immense opportunities arising from China's rapidly expanding and thriving medical and healthcare industries and beyond. Going forward, we believe the new names will better reflect our corporate vision as underpinned by the Group's strategic developments, effectively highlighting the diversity and depth of our diversified and growing healthcare operations built around its core competences in healthcare and medical industry."
About the Group:
Golden Meditech Holdings Limited is China's leading integrated healthcare device and service operator, and the first medical device enterprise that was publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEX). Golden Meditech is a first-mover in China's medical devices, cord blood banking, having established dominant positions in these respective areas over the years, thanks to its strengths in innovation and market expertise, as well as its ability in capturing emerging market opportunities. Going forward, the Group will continue its pursuit in becoming China's leading integrated medical group both through organic growth and strategic expansion.
For inquiry, please kindly contact: Investor Relations Division Golden Meditech Holdings Limited Address: 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong. Tel: +852-3605-8138 Fax: +852-3605-8181 Email: email@example.com
SOURCE Golden Meditech Holdings LimitedBack to top
|SOURCE Golden Meditech Holdings Limited|
Copyright©2010 PR Newswire.
All rights reserved